Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation (CDSCO) for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies. This is India’s first in...
CBI arrests two CDSCO medical device officers in Rs 3.50 lakh bribery case [Zee News] Explained: What are the new restrictions under Kerala ‘triple lockdown’? [The Indian Express] 16th May 2021 Cyclone Tauktae Live Updates: Very severe cyclonic storm likely to intensify further, warns IMD;...
Under CDSCO, the Drug Controller General of India (DCGI) regulates all related activities [7]. In India, as indicated by the Drug and Cosmetics Act, labels, whether external or internal, should contain the name of the cosmetics and the address of the manufacturer. If the size of the ...
Wockhardt Gets CDSCO Nod for Exporting Up to 100 Million Doses of Sputnik Vaccines 22-02-07 CI Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 3rd Quarter Results for Financial Year 2021-22, today 22-01-28 AQ Wockhardt Turns to Loss in Fiscal Q3 22-01-...
Elaborating on the steps taken by the government for timely availability of Covid-19 drugs and vaccination, Choubey informed that CDSCO has approved the manufacturing and marketing of three drugs — Remdesivir Injectable formulations, Favipiravir tablets, Itolizumab injection — ...